Acupuncture for pain in sickle cell disease
Part of Blood & lymphatic, Genetic & congenital, Pain clinical trials.
This trial tests whether adding acupuncture to standard pain treatments can help manage pain in people with sickle cell disease. It involves brain scans, questionnaires, and acupuncture sessions to see if this approach reduces pain and improves quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 14 and 80 years old and have sickle cell disease (any type like SS, SC, etc.).
- You have had chronic pain for at least 6 months OR a pain crisis in the past year.
- You are right-handed.
- You are willing to travel for study visits and receive acupuncture up to twice a week for 5 weeks.
- You have not had acupuncture in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what causes pain in people with sickle cell disease. They hope to learn more about pain patterns to better help patients manage it.
This trial tests if cannabidiol (CBD) can help reduce pain interference in adults with sickle cell disease. You will take CBD daily for 4 weeks and report your pain levels.
This trial tests a safe, non-drug device that gently stimulates the ear to help reduce pain in children with sickle cell disease who are in the hospital for a pain crisis. It may offer a new way to manage pain without extra medication.
This study tests if music therapy can improve quality of life for people with sickle cell disease who have chronic pain. You would join a music therapy group and share your feedback to help researchers see if this approach helps.
This trial tests CS-206, an experimental therapy for people with sickle cell disease. It aims to reduce severe complications like pain crises, acute chest syndrome, strokes, and other serious events. You may qualify if you have a specific genetic type of sickle cell disease and have experienced complications despite standard treatments.
This trial tests a new treatment called CS-206 for adolescents with severe sickle cell disease. It aims to see if this treatment can help by making stem cell transplants safer and more effective for people who have not done well with standard care.
Hear when a new Sickle Cell Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.